Patents by Inventor Catherine Marie Smith

Catherine Marie Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20240101422
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: July 25, 2023
    Publication date: March 28, 2024
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium thiosulfate-containing pharmaceutical compositions
    Patent number: 11753301
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Grant
    Filed: February 13, 2023
    Date of Patent: September 12, 2023
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium thiosulfate-containing pharmaceutical compositions
    Patent number: 11753300
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: September 12, 2023
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20230256006
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Application
    Filed: January 18, 2023
    Publication date: August 17, 2023
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20230183067
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: February 13, 2023
    Publication date: June 15, 2023
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium nitrite-containing pharmaceutical compositions
    Patent number: 11583550
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: February 21, 2023
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220063999
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: September 8, 2021
    Publication date: March 3, 2022
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium thiosulfate-containing pharmaceutical compositions
    Patent number: 11142456
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: October 12, 2021
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210100833
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Application
    Filed: December 18, 2020
    Publication date: April 8, 2021
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium nitrite-containing pharmaceutical compositions
    Patent number: 10898513
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: January 26, 2021
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium nitrite-containing pharmaceutical compositions
    Patent number: 10874691
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: December 29, 2020
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20200317520
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: June 19, 2020
    Publication date: October 8, 2020
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20200237809
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Application
    Filed: April 8, 2020
    Publication date: July 30, 2020
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium thiosulfate-containing pharmaceutical compositions
    Patent number: 10723623
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: July 28, 2020
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20200016193
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Application
    Filed: September 23, 2019
    Publication date: January 16, 2020
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium thiosulfate-containing pharmaceutical compositions
    Patent number: 10479686
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: November 19, 2019
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium thiosulfate-containing pharmaceutical compositions
    Patent number: 10479687
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: November 19, 2019
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium nitrite-containing pharmaceutical compositions
    Patent number: 10456417
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: October 29, 2019
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20190144276
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: January 15, 2019
    Publication date: May 16, 2019
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium nitrite-containing pharmaceutical compositions
    Patent number: 10251910
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: April 9, 2019
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze